These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 20170727

  • 1. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms.
    Nailis H, Vandenbosch D, Deforce D, Nelis HJ, Coenye T.
    Res Microbiol; 2010 May; 161(4):284-92. PubMed ID: 20170727
    [Abstract] [Full Text] [Related]

  • 2. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
    Borecká-Melkusová S, Moran GP, Sullivan DJ, Kucharíková S, Chorvát D, Bujdáková H.
    Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
    [Abstract] [Full Text] [Related]

  • 3. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
    Bruzual I, Riggle P, Hadley S, Kumamoto CA.
    J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A, Saddi M, Cardia MC, Borgna R, Sanna C, Saddi B, Maccioni E.
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M, Karaman M.
    Mikrobiyol Bul; 2004 May; 38(1-2):91-8. PubMed ID: 15293907
    [Abstract] [Full Text] [Related]

  • 9. Comparison between allicin and fluconazole in Candida albicans biofilm inhibition and in suppression of HWP1 gene expression.
    Khodavandi A, Harmal NS, Alizadeh F, Scully OJ, Sidik SM, Othman F, Sekawi Z, Ng KP, Chong PP.
    Phytomedicine; 2011 Dec 15; 19(1):56-63. PubMed ID: 21924600
    [Abstract] [Full Text] [Related]

  • 10. In vitro method to study antifungal perfusion in Candida biofilms.
    Samaranayake YH, Ye J, Yau JY, Cheung BP, Samaranayake LP.
    J Clin Microbiol; 2005 Feb 15; 43(2):818-25. PubMed ID: 15695686
    [Abstract] [Full Text] [Related]

  • 11. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T, Samaranayake LP, Jayatilake JA, Egusa H, Yatani H, Seneviratne CJ.
    Int J Antimicrob Agents; 2009 Oct 15; 34(4):333-9. PubMed ID: 19376687
    [Abstract] [Full Text] [Related]

  • 12. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans.
    Khan MS, Ahmad I.
    J Ethnopharmacol; 2012 Mar 27; 140(2):416-23. PubMed ID: 22326355
    [Abstract] [Full Text] [Related]

  • 13. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Melkusová S, Bujdáková H, Volleková A, Myoken Y, Mikami Y.
    Pharmazie; 2004 Jul 27; 59(7):573-4. PubMed ID: 15296100
    [Abstract] [Full Text] [Related]

  • 14. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
    Lamfon H, Porter SR, McCullough M, Pratten J.
    J Antimicrob Chemother; 2004 Feb 27; 53(2):383-5. PubMed ID: 14729749
    [Abstract] [Full Text] [Related]

  • 15. Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm.
    Yu LH, Wei X, Ma M, Chen XJ, Xu SB.
    Antimicrob Agents Chemother; 2012 Feb 27; 56(2):770-5. PubMed ID: 22106223
    [Abstract] [Full Text] [Related]

  • 16. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
    Yang YL, Li SY, Cheng HH, Lo HJ, TSARY Hospitals.
    Diagn Microbiol Infect Dis; 2005 Mar 27; 51(3):179-83. PubMed ID: 15766603
    [Abstract] [Full Text] [Related]

  • 17. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
    Konopka K, Dorocka-Bobkowska B, Gebremedhin S, Düzgüneş N.
    Antonie Van Leeuwenhoek; 2010 May 27; 97(4):413-7. PubMed ID: 20140514
    [Abstract] [Full Text] [Related]

  • 18. The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans.
    Sasse C, Dunkel N, Schäfer T, Schneider S, Dierolf F, Ohlsen K, Morschhäuser J.
    Mol Microbiol; 2012 Nov 27; 86(3):539-56. PubMed ID: 22924823
    [Abstract] [Full Text] [Related]

  • 19. Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals.
    Watamoto T, Samaranayake LP, Egusa H, Yatani H, Seneviratne CJ.
    J Med Microbiol; 2011 Sep 27; 60(Pt 9):1241-1247. PubMed ID: 21474609
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth.
    Haque F, Alfatah M, Ganesan K, Bhattacharyya MS.
    Sci Rep; 2016 Mar 31; 6():23575. PubMed ID: 27030404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.